Progress in coverage with hepatitis B vaccine among US children, 1994-1997

被引:8
作者
Yusuf, HR
Coronado, VG
Averhoff, FA
Maes, EF
Rodewald, LE
Battaglia, MP
Mahoney, FJ
机构
[1] Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Immunizat Program, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Data Management Div, Natl Immunizat Program, Atlanta, GA USA
[3] ABT Associates Inc, Cambridge, MA 02138 USA
[4] Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA
关键词
D O I
10.2105/AJPH.89.11.1684
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. This study was done to assess progress in hepatitis B vaccination of children from 1994 through 1997. Methods. We used data from the National Immunization Survey (NIS), a random-digit-dialed telephone survey that includes a mail survey to verify vaccination providers' records. The NIS is conducted in 78 geographic areas (50 states and 28 selected urban areas) in the United States. Results. A total of 32433 household interviews were completed in the 1997 NIS. An estimated 83.7% of children aged 19 to 35 months received 3 or more doses of hepatitis B vaccine. Coverage with 3 doses was greater (86.7%) among children in states that had day care entry requirements for hepatitis B vaccination than among children in states without such requirements (83.0%) and was greater among children from families with incomes at or above the poverty level (85.0%) than among children below the poverty level (80.6%). Hepatitis B vaccination of children increased from 1994 through 1996, from 41% to 84%, but coverage reached a constant level of 84% to 85% in 1996/97. Conclusion. Although substantial progress has been made in fully vaccinating children against hepatitis B, greater efforts are needed to ensure that all infants receive 3 doses of hepatitis B vaccine.
引用
收藏
页码:1684 / 1689
页数:6
相关论文
共 30 条
[1]  
*AM AC FAM PHYS, 1992, REC HEP B PREEXP VAC
[2]  
[Anonymous], 1994, MMWR Recomm Rep, V43, P1
[3]  
[Anonymous], 1991, DHHS PUBL PHS
[4]  
*CDC, 1990, MMWR-MORBID MORTAL W, V39, P5
[5]  
*CDC, 1991, MMWR-MORBID MORTAL W, V40, P1
[6]  
*CDCP, 1993, MMWR-MORBID MORTAL W, V42, P985
[7]  
*CDCP, 1994, MMWR-MORBID MORTAL W, V43, P57
[8]  
Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P963
[9]  
Cochran WG, 1977, SAMPLING TECHNIQUES, P327, DOI [10.1201/9780429296284, DOI 10.1201/9780429296284]
[10]  
Freed GL, 1996, J FAM PRACTICE, V42, P587